ImClone have initiated a phase II clinical trial of VEGFR-2 MAb IMC-1121B in patients with advanced ovarian cancer. … more →
Kinase Newscrimsoncanary wrote 9 months ago: ImClone have initiated a phase II clinical trial of VEGFR-2 MAb IMC-1121B in patients with a … more →
crimsoncanary wrote 10 months ago: ImClone have commenced enrollment in a Phase II trial with either IMC-A12 or IMC-1121B in patients w … more →
Sitemaster wrote 10 months ago: ImClone Systems has announced the initiation of enrollment of patients with androgen-independent pro … more →
crimsoncanary wrote 11 months ago: ImClone Systems have initiated a global Phase 3 clinical trial of VEGFR2 MAb IMC-1121B in women with … more →